{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:08:41Z","timestamp":1794722921937,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ijpharm.2009.05.024","type":"journal-article","created":{"date-parts":[[2009,5,23]],"date-time":"2009-05-23T08:56:36Z","timestamp":1243068996000},"page":"9-16","source":"Crossref","is-referenced-by-count":23,"title":["New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments"],"prefix":"10.1016","volume":"378","author":[{"given":"Huyen Thi Thanh","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Ha Lien","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2009.05.024_bib1","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/jps.21240","article-title":"Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier","volume":"97","author":"Catalioto","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201052772834","article-title":"Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery","volume":"2","author":"Cebrian","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/mp060121r","article-title":"Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity","volume":"4","author":"Collnot","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib4","series-title":"Drug Absorption Enhancement: Concepts, Possibilities, Limitations and Trends","first-page":"367","article-title":"Safety assessment of intestinal permeability enhancers","author":"Curatolo","year":"1994"},{"key":"10.1016\/j.ijpharm.2009.05.024_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/03639049809082364","article-title":"Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat","volume":"24","author":"Dangi","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayer","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/mp060042f","article-title":"The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests","volume":"3","author":"Kim","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1248\/cpb.25.1243","article-title":"Factors influencing absorption and excretion of drugs. VI. Effect of sodium cholate on in situ rat intestinal absorption of buformin","volume":"25","author":"Kojima","year":"1977","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/BF02975212","article-title":"Solubility and stability of melatonin in propylene glycol and 2-hydoxypropyl-\u03b2-cyclodextrin vehicles","volume":"20","author":"Lee","year":"1997","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-5173(95)00088-Z","article-title":"Design and evaluation of an oral controlled release delivery system for melatonin in human subjects","volume":"124","author":"Lee","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1081\/DDC-100102199","article-title":"Formulation and release characteristics of hydroxypropylmethylcellulose matrix tablet containing melatonin","volume":"25","author":"Lee","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.30.1301","article-title":"Effect of labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine 123, a P-glycoprotein substrate in rats","volume":"30","author":"Lin","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0006-2952(99)00377-9","article-title":"Effect of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats","volume":"59","author":"Lo","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2005.11.011","article-title":"Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine","volume":"111","author":"Martin","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2009.05.024_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2006.06.004","article-title":"Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract","volume":"29","author":"Masaoka","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1016062224568","article-title":"Estimation of the increase in solubility of drugs as a function of bile salt concentration","volume":"13","author":"Mithani","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib17","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","article-title":"Melatonin: Nature's most versatile biological signal?","volume":"273","author":"Pandi","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.addr.2005.01.024","article-title":"Pharmaceutical application of magnetic resonance imaging (MRI)","volume":"57","author":"Richardson","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.farmac.2005.08.008","article-title":"Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers","volume":"60","author":"Sharma","year":"2005","journal-title":"Farmaco"},{"key":"10.1016\/j.ijpharm.2009.05.024_bib20","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/S0024-3205(99)00519-6","article-title":"High physiological levels of melatonin in the bile of mammals","volume":"65","author":"Tan","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/A:1015999309353","article-title":"Enhancement of colonic drug absorption by the paracellular permeation route","volume":"5","author":"Tomita","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1211\/0022357021779159","article-title":"Effect of dietary fatty acids on the intestinal permeability of marker drug compounds in excised rat jejunum","volume":"54","author":"Vine","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/156720106777731073","article-title":"Pineal hormone melatonin: solubilization studies in model aqueous gastrointestinal environments","volume":"3","author":"Vlachou","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib24","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0169-409X(01)00183-1","article-title":"Intestinal drug efflux: formulation and food effects","volume":"50","author":"Wagner","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib25","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1248\/cpb.34.3362","article-title":"Intestinal absorption of a beta-adrenergic blocking agent nadolol. I. Comparison of absorption behavior of nadolol with those of other beta-blocking agents in rats","volume":"34","author":"Yamaguchi","year":"1986","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib26","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1248\/cpb.34.3836","article-title":"Intestinal absorption of a beta-adrenergic blocking agent nadolol. II. Mechanism of the inhibitory effect on the intestinal absorption of nadolol by sodium cholate in rats","volume":"34","author":"Yamaguchi","year":"1986","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib27","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1248\/cpb.34.4259","article-title":"Intestinal absorption of a beta-adrenergic blocking agent nadolol. III. Nuclear magnetic resonance spectroscopic study on nadolol-sodium cholate micellar complex and intestinal absorption of nadolol derivatives in rats","volume":"34","author":"Yamaguchi","year":"1986","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2009.05.024_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejps.2004.04.004","article-title":"Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (Caco-2 cell monolayers) and in vivo models","volume":"22","author":"Zornoza","year":"2004","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517309003305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517309003305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T10:50:38Z","timestamp":1545216638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517309003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0378517309003305"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2009.05.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}